Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Volume - 13 | Issue-1
Covid-19 has hit the world population and the ultimate aim now is survival. At risk groups are being defined by age, comorbidities, and risk of exposure. We must also keep the immunocompromised patients in mind. The critically ill patients cannot afford a delay in treatment